VS
Vikram Singh Kanawat
About Vikram Singh Kanawat
Data last updated:
Vikram Singh Kanawat is a Director at Nutraxone Healthcare Private Limited (since 2022). The company operates in Healthcare. Nutraxone Healthcare Private Limited reported revenue of ₹15.2 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nutraxone Healthcare Private Limited U24230RJ2022PTC084750 | Director | 21 Nov 2022 | 2022 | ₹15.2 Lakh (FY 2023) | Active |
Board colleagues of Vikram Singh Kanawat
| Name | DIN | Company | Designation |
|---|---|---|---|
| Suresh Jain | 09797772 | Nutraxone Healthcare Private Limited | Director |
| Vikas Patodiya | 09797783 | Nutraxone Healthcare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vikram Singh Kanawat
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vikram Singh Kanawat
Vikram Singh Kanawat currently holds 1 directorship: Nutraxone Healthcare Private Limited (Director, since 21 Nov 2022, revenue ₹15.2 Lakh (FY 2023)).
Vikram Singh Kanawat was first appointed on 21 Nov 2022 as Director at Nutraxone Healthcare Private Limited.
The current boards of Vikram Singh Kanawat's companies include Suresh Jain (Nutraxone Healthcare Private Limited), Vikas Patodiya (Nutraxone Healthcare Private Limited).